Premium
Letter: predicting treatment discontinuation in inflammatory bowel disease—anti‐TNF trough levels and anti‐drug antibodies. Authors’ reply
Author(s) -
Roblin Xavier,
Nancey Stephane,
Paul Stéphane
Publication year - 2021
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.16501
Subject(s) - medicine , discontinuation , inflammatory bowel disease , drug , antibody , trough (economics) , gastroenterology , tumor necrosis factor alpha , disease , immunology , pharmacology , economics , macroeconomics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom